ArticleFrontiers in endocrinology2025
Epidemiology and temporal trends of childhood type 1 diabetes in China: an analysis of the GBD 2021.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy of Nurse-Led WIKAP Intervention on Hypoglycemia Coping Confidence and Outcomes in Adolescents with Type 1 Diabetes Mellitus: A Quasi-Experimental Study in Zhijiang, China.Patient preference and adherence · 2026Trial
- Insulin is central, plasmapheresis is salvage: clinical spectrum and management of severe hypertriglyceridemia in 21 children with diabetic ketoacidosis.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study investigates the epidemiological trends of childhood type 1 diabetes (T1D) in China and establishes predictive models to estimate future disease burden. Methods: Temporal trend analyses were performed using data from the Global Burden of Disease (GBD) database, stratified by age and sex. Joinpoint regression analysis was applied to evaluate changes in incidence and mortality rates from 1990 to 2021, complemented by autoregressive integrated moving average (ARIMA) and exponential smoothing state space (ETS) models to project disease trends through 2040. Results: The results indicate a rising trend in the incidence of childhood T1D among Chinese children aged 0-14 years, alongside an overall decline in mortality, reflecting an epidemiological pattern characterized by low incidence yet non-negligible mortality. Notably, infants < 1 year of age have shown increasing mortality rates in recent years. Projections indicate that both incidence and mortality in this age group will continue to increase through 2040. Additionally, incidence among children 1 year of age also expected to persist on an upward trajectory. Sex-based disparities were evident, with girls bearing a higher disease burden than boys, as indicated by elevated incidence, mortality and underdiagnosis rates. Conclusion: These findings necessitate enhanced public health and clinical management strategies for childhood T1D in China, specifically targeting underdiagnosis reduction, incidence rate stabilization, and mortality rate improvement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.